SCHEMBL3598897

SCHEMBL3598897

CCc1nn(C(N)=O)c2cc(C(=O)OC)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 2/20 0.42
KDM4E B2RXH2 4/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
KIF11 P52732 1/20 0.40
RAB9A P51151 1/20 0.40
ALDH1A1 P00352 3/20 0.39
HSD17B10 Q99714 3/20 0.39
TSHR P16473 1/20 0.39
NPC1 O15118 1/20 0.39
TLR7 Q9NYK1 1/20 0.39
ATM Q13315 2/20 0.38
GLA P06280 2/20 0.38
GAA P10253 2/20 0.38
HPGD P15428 2/20 0.38
MAPT P10636 2/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LCK P06239 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27272748 0.83 SLC22A12 (0.44) SLC22A12KDM4EKMT2AMEN1KIF11
SCHEMBL7981706 0.80 KDM4E (0.44) SLC22A12KDM4EKMT2AMEN1KIF11
SCHEMBL7984355 0.76 DGAT2 (0.48) KHKPARP1
SCHEMBL3605146 0.76 MERTK (0.46) SLC22A12KDM4EKMT2AMEN1ALDH1A1
SCHEMBL7981717 0.76 MERTK (0.44) SLC22A12KDM4EKMT2AMEN1ALDH1A1
SCHEMBL7970829 0.76 SLC22A12 (0.47) SLC22A12KDM4EKMT2AMEN1ALDH1A1
SCHEMBL7971299 0.75 MERTK (0.48) SLC22A12KDM4ERAB9AALDH1A1TSHR
SCHEMBL27541375 0.75 SLC22A12 (0.47) SLC22A12KDM4EKMT2AMEN1KIF11
SCHEMBL28136631 0.75 ALOX15 (0.47) KDM4EALDH1A1L3MBTL1KHK
SCHEMBL28468125 0.75 LOXL2 (0.46) KDM4EKMT2AKIF11RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7723348-B2 Phosphodiesterase 4 inhibitors MEMORY PHARMACEUTICALS CORPORATION (US) 2010-05-25 US disclosed
US-7432266-B2 Phosphodiesterase 4 inhibitors MEMORY PHARMACEUTICALS CORPORATION (US) 2008-10-07 US disclosed
US-20080207660-A1 PHOSPHODIESTERASE 4 INHIBITORS HOPPER ALLEN 2008-08-28 US disclosed
WO-2007123953-A2 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2007-11-01 WO disclosed
US-20070254913-A1 Phosphodiesterase 4 inhibitors MEMORY PHARMACEUTICALS CORPORATION 2007-11-01 US disclosed
EP-1799673-A1 PYRAZOLE DERIVATIVES AS PHOSPHODIESTERASE 4 INHIBITORS Memory Pharmaceuticals Corporation (US) 2007-06-27 EP disclosed
US-20060154960-A1 Phosphodiesterase 4 inhibitors MEMORY PHARMACEUTICALS CORPORATION 2006-07-13 US disclosed
WO-2006044528-A1 PYRAZOLE DERIVATIVES AS PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2006-04-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254913-A1 Phosphodiesterase 4 inhibitors PDE4A, PDE4B, PDE12 SLC22A12 2455/4885KDM4E 209/4885KMT2A 1669/4885
US-20080207660-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE12 SLC22A12 2455/4885KDM4E 209/4885KMT2A 1669/4885
US-20060154960-A1 Phosphodiesterase 4 inhibitors PDE4A, PDE4B, PDE12 SLC22A12 2455/4885KDM4E 209/4885KMT2A 1669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.